Ignite Creation Date:
2024-05-06 @ 7:17 AM
Last Modification Date:
2024-10-26 @ 11:47 AM
Study NCT ID:
NCT02508467
Status:
COMPLETED
Last Update Posted:
2024-04-12
First Post:
2015-07-09
Brief Title:
A Phase 1 Study of Fisogatinib BLU-554 in Patients With Hepatocellular Carcinoma
Sponsor:
Blueprint Medicines Corporation
Organization:
Blueprint Medicines Corporation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-31
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-28
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-09
First Submit QC Date:
July 23 2015
Study First Post Date:
2015-07-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-10
Last Update Post Date:
2024-04-12
Last Update Post Date Type:
ACTUAL